Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Legionnaires' disease in Switzerland: rationale and study protocol of a prospective national case-control and molecular source attribution study (SwissLEGIO)
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4700026
Author(s) Fischer, F. B.; Bigler, M.; Mäusezahl, D.; Hattendorf, J.; Egli, A.; Julian, T. R.; Rölli, F.; Gaia, V.; Wymann, M.; Fridez, F.; Bertschi, S.
Author(s) at UniBasel Fischer, Fabienne
Bigler, Melina
Mäusezahl, Daniel
Hattendorf, Jan
Julian, Timothy
Year 2023
Title Legionnaires' disease in Switzerland: rationale and study protocol of a prospective national case-control and molecular source attribution study (SwissLEGIO)
Journal Infection
Volume 51
Number 5
Pages / Article-Number 1467-1479
Keywords Humans; *Legionnaires' Disease/epidemiology/diagnosis; *Legionella pneumophila/genetics; Switzerland/epidemiology; Prospective Studies; Disease Outbreaks; Case-Control Studies; Case–control study; Legionella spp.; Legionnaires’ disease; Surveillance; Switzerland; Whole genome sequencing
Mesh terms Humans; Legionnaires' Disease, diagnosis; Legionella pneumophila, genetics; Switzerland, epidemiology; Prospective Studies; Disease Outbreaks; Case-Control Studies
Abstract Switzerland has one of the highest annual Legionnaires' disease (LD) notification rates in Europe (7.8 cases/100,000 population in 2021). The main sources of infection and the cause for this high rate remain largely unknown. This hampers the implementation of targeted Legionella spp. control efforts. The SwissLEGIO national case-control and molecular source attribution study investigates risk factors and infection sources for community-acquired LD in Switzerland. Over the duration of one year, the study is recruiting 205 newly diagnosed LD patients through a network of 20 university and cantonal hospitals. Healthy controls matched for age, sex, and residence at district level are recruited from the general population. Risk factors for LD are assessed in questionnaire-based interviews. Clinical and environmental Legionella spp. isolates are compared using whole genome sequencing (WGS). Direct comparison of sero- and sequence types (ST), core genome multilocus sequencing types (cgMLST), and single nucleotide polymorphisms (SNPs) between clinical and environmental isolates are used to investigate the infection sources and the prevalence and virulence of different Legionella spp. strains detected across Switzerland. The SwissLEGIO study innovates in combining case-control and molecular typing approaches for source attribution on a national level outside an outbreak setting. The study provides a unique platform for national Legionellosis and Legionella research and is conducted in an inter- and transdisciplinary, co-production approach involving various national governmental and national research stakeholders.
ISSN/ISBN 0300-8126
URL https://doi.org/10.1007/s15010-023-02014-x
edoc-URL https://edoc.unibas.ch/95970/
Full Text on edoc Available
Digital Object Identifier DOI 10.1007/s15010-023-02014-x
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/36905400
ISI-Number WOS:000946962500001
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.329 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
20/06/2024